Arbutus Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 6,255 | 0.00347% |
Individual Insiders | 2,836,191 | 1.57% |
Hedge Funds | 22,238,989 | 12.3% |
Public Companies | 38,847,462 | 21.6% |
Institutions | 56,422,901 | 31.3% |
General Public | 59,823,132 | 33.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
38,847,462 | US$102.6m | 0% | no data | |||
13,197,062 | US$34.8m | 10.9% | 21.97% | |||
10,390,300 | US$27.4m | 1.13% | no data | |||
9,041,927 | US$23.9m | 9.19% | 5.79% | |||
6,388,786 | US$16.9m | 29.5% | 0.01% | |||
5,988,883 | US$15.8m | 0.69% | no data | |||
4,719,903 | US$12.5m | 0% | 0.14% | |||
4,139,904 | US$10.9m | -0.24% | 0.11% | |||
3,468,824 | US$9.2m | 0% | 3.91% | |||
2,817,695 | US$7.4m | 4.47% | no data | |||
2,396,760 | US$6.3m | 10.9% | no data | |||
1,933,958 | US$5.1m | -4.17% | 0.01% | |||
1,537,924 | US$4.1m | -2.88% | no data | |||
1,487,983 | US$3.9m | 1.18% | no data | |||
1,420,720 | US$3.8m | 32.6% | 0.3% | |||
1,367,039 | US$3.6m | 0% | 0.04% | |||
1,325,193 | US$3.5m | 1.36% | no data | |||
1,090,851 | US$2.9m | -18.7% | 1.56% | |||
1,068,221 | US$2.8m | 0.27% | no data | |||
817,574 | US$2.2m | 0% | 0.01% | |||
470,450 | US$1.2m | 68.9% | no data | |||
456,828 | US$1.2m | 1.19% | no data | |||
453,628 | US$1.2m | -7.75% | 0.05% | |||
387,241 | US$1.0m | -1.43% | 0.02% | |||
352,265 | US$930.0k | 10% | no data |